作者
Wouter P Kluijfhout, Jesse D Pasternak, Jessica E Gosnell, Wen T Shen, Quan-Yang Duh, Menno R Vriens, Bart De Keizer, Thomas A Hope, Christine M Glastonbury, Miguel H Pampaloni, Insoo Suh
发表日期
2017/8
期刊
Radiology
卷号
284
期号
2
页码范围
460-467
出版商
Radiological Society of North America
简介
Purpose
To investigate the performance of flourine 18 (18F) fluorocholine (FCH) positron emission tomography (PET)/magnetic resonance (MR) imaging in patients with hyperparathyroidism and nonlocalized disease who have negative or inconclusive results at ultrasonography (US) and technetium 99m (99mTc) sestamibi scintigraphy.
Materials and Methods
This study was approved by the institutional review board. Between May and December 2015, 10 patients (mean age, 70.4 years; range, 58–82 years) with biochemical primary hyperparathyroidism and inconclusive results at US and 99mTc sestamibi scintigraphy were prospectively enrolled. All patients gave informed consent. Directly after administration of 3 MBq/kg of FCH, PET imaging was performed, followed by T1- and T2-weighted MR imaging before and after gadolinium enhancement. Intraoperative localization and histologic results were the reference …
学术搜索中的文章
WP Kluijfhout, JD Pasternak, JE Gosnell, WT Shen… - Radiology, 2017